The potential of the DAPK1 loss gene signature for metastasis prediction and therapy resistance should be further investigated.References Remmele, W. & Stegner, H. E. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) ...
Moreover, the ability of shRNA-targeting DAP5 to sensitize human cancer cells treated with the anticancer drug taxol to apoptosis indicates that DAP5 has an excellent potential to serve as a target for anticancer therapy in the future. Experimental Procedures Cell Cultures, Synchronization Procedures...